124 related articles for article (PubMed ID: 26648486)
41. A novel mouse model of gastric cancer with human gastric microenvironment.
Zheng MJ; Wang J; Chen YW; Xu L; Xue DD; Fu W; Zhang YF; Du Q; Zhao Y; Ling LJ; Ding Q; Liu XA; Zha XM; Zheng W; Xia TS; Wang S
Cancer Lett; 2012 Dec; 325(1):108-15. PubMed ID: 22750094
[TBL] [Abstract][Full Text] [Related]
42. Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression.
Tonry C; Armstrong J; Pennington SR
Oncotarget; 2017 Feb; 8(9):14374-14394. PubMed ID: 28086232
[TBL] [Abstract][Full Text] [Related]
43. Signal transducers and activators of transcription 3-induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase-3β.
Yoon J; Ko YS; Cho SJ; Park J; Choi YS; Choi Y; Pyo JS; Ye SK; Youn HD; Lee JS; Chang MS; Kim MA; Lee BL
APMIS; 2015 May; 123(5):373-82. PubMed ID: 25846563
[TBL] [Abstract][Full Text] [Related]
44. CRISPR/Cas9-mediated knockout of the PDEF gene inhibits migration and invasion of human gastric cancer AGS cells.
Zhang YQ; Pei JH; Shi SS; Guo XS; Cui GY; Li YF; Zhang HP; Hu WQ
Biomed Pharmacother; 2019 Mar; 111():76-85. PubMed ID: 30576937
[TBL] [Abstract][Full Text] [Related]
45. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection.
Xiao H; Zhang Y; Kim Y; Kim S; Kim JJ; Kim KM; Yoshizawa J; Fan LY; Cao CX; Wong DT
Sci Rep; 2016 Feb; 6():22165. PubMed ID: 26911362
[TBL] [Abstract][Full Text] [Related]
46. Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping.
Rontogianni S; Synadaki E; Li B; Liefaard MC; Lips EH; Wesseling J; Wu W; Altelaar M
Commun Biol; 2019; 2():325. PubMed ID: 31508500
[TBL] [Abstract][Full Text] [Related]
47. Comparing intestinal versus diffuse gastric cancer using a PEFF-oriented proteomic pipeline.
Wippel HH; Santos MDM; Clasen MA; Kurt LU; Nogueira FCS; Carvalho CE; McCormick TM; Neto GPB; Alves LR; da Gloria da Costa Carvalho M; Carvalho PC; Fischer JSDG
J Proteomics; 2018 Jan; 171():63-72. PubMed ID: 29032071
[TBL] [Abstract][Full Text] [Related]
48. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
[TBL] [Abstract][Full Text] [Related]
49. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
50. miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.
Tao Y; Song Y; Han T; Wang C; Zhao T; Gu Y
Biomed Pharmacother; 2017 Dec; 96():191-197. PubMed ID: 28987942
[TBL] [Abstract][Full Text] [Related]
51. The roles of HOXB7 in promoting migration, invasion, and anti-apoptosis in gastric cancer.
Joo MK; Park JJ; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
J Gastroenterol Hepatol; 2016 Oct; 31(10):1717-1726. PubMed ID: 26968988
[TBL] [Abstract][Full Text] [Related]
52. Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome.
Lu X; Fu Y; Gu L; Zhang Y; Liao AY; Wang T; Jia B; Zhou D; Liao L
Mol Oncol; 2023 Feb; 17(2):261-283. PubMed ID: 36520032
[TBL] [Abstract][Full Text] [Related]
53. Mitochondrial Proteomics Approach Reveals Voltage-Dependent Anion Channel 1 (VDAC1) as a Potential Biomarker of Gastric Cancer.
Gao W; Xua J; Wang F; Zhang L; Peng R; Zhu Y; Tang Q; Wu J
Cell Physiol Biochem; 2015; 37(6):2339-54. PubMed ID: 26646027
[TBL] [Abstract][Full Text] [Related]
54. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer.
Loei H; Tan HT; Lim TK; Lim KH; So JB; Yeoh KG; Chung MC
J Proteome Res; 2012 Mar; 11(3):1759-72. PubMed ID: 22204653
[TBL] [Abstract][Full Text] [Related]
55. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
[TBL] [Abstract][Full Text] [Related]
56. Urinary Proteomics for Discovery of Gastric Cancer Biomarkers to Enable Precision Clinical Oncology.
Joshi N; Bhat F; Bellad A; Sathe G; Jain A; Chavan S; Sirdeshmukh R; Pandey A
OMICS; 2023 Aug; 27(8):361-371. PubMed ID: 37579183
[TBL] [Abstract][Full Text] [Related]
57. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
Peng W; Zhang Y; Zhu R; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
[TBL] [Abstract][Full Text] [Related]
58. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
Tao Y; Sun C; Zhang T; Song Y
Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
[TBL] [Abstract][Full Text] [Related]
59. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer.
Wei LM; Cao S; Yu WD; Liu YL; Wang JT
Oncol Rep; 2015 Feb; 33(2):615-24. PubMed ID: 25482732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
